NCT00344006 - Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria | Biotech Hunter

Enrollment

1,395

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Malaria, Falciparum

Interventions

DRUG

chlorproguanil-dapsone-artesunate

DRUG

artemether-lumefantrine

Trial Locations (9)

GSK Investigational Site, Bobo-Dioulasso

GSK Investigational Site, Kintampo

GSK Investigational Site, Eldoret

GSK Investigational Site, Kilifi

GSK Investigational Site, Barkin Ladi

GSK Investigational Site, Calabar

GSK Investigational Site, Enugu

GSK Investigational Site, Ibadan

GSK Investigational Site, Ifakara